1. Home
  2. NMG vs CADL Comparison

NMG vs CADL Comparison

Compare NMG & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nouveau Monde Graphite Inc.

NMG

Nouveau Monde Graphite Inc.

N/A

Current Price

$1.34

Market Cap

414.7M

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.59

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMG
CADL
Founded
2011
1999
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
414.7M
1.0B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
NMG
CADL
Price
$1.34
$10.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$5.75
$19.00
AVG Volume (30 Days)
352.0K
1.2M
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$4.35
52 Week High
$6.06
$14.00

Technical Indicators

Market Signals
Indicator
NMG
CADL
Relative Strength Index (RSI) 42.03 42.84
Support Level $1.26 $4.91
Resistance Level $1.64 $11.36
Average True Range (ATR) 0.06 0.69
MACD -0.01 -0.26
Stochastic Oscillator 5.26 5.54

Price Performance

Historical Comparison
NMG
CADL

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: